請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/46428完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 賈景山(Jean-San Chia) | |
| dc.contributor.author | Chieh-Jen Cheng | en |
| dc.contributor.author | 鄭傑仁 | zh_TW |
| dc.date.accessioned | 2021-06-15T05:08:33Z | - |
| dc.date.available | 2015-09-09 | |
| dc.date.copyright | 2010-09-09 | |
| dc.date.issued | 2010 | |
| dc.date.submitted | 2010-07-26 | |
| dc.identifier.citation | Adler A, Litmanovitz I, Bauer S and Dolfin T (2004). 'Aspirin treatment for neonatal infectious endocarditis.' Pediatric Cardiology 25(5): 562-564.
Ajdić D, McShan WM, McLaughlin RE, Savić G, Chang J, Carson MB, Primeaux C, Tian R, Kenton S, Jia H, Lin S, Qian Y, Li S, Zhu H, Najar F, Lai H, White J, Roe BA and Ferretti JJ (2002). 'Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen.' Proceedings of the National Academy of Sciences of the United States of America 99(22): 14434-14439. Anavekar NS, Tleyjeh IM, Anavekar NS, Mirzoyev Z, Steckelberg JM, Haddad C, Khandaker MH, Wilson WR, Chandrasekaran K and Baddour LM (2007). 'Impact of Prior Antiplatelet Therapy on risk of embolism in infective endocarditis.' Clinical Infectious Diseases 44(9): 1180-1186. Aslam R, Speck ER, Kim M, Crow AR, Bang KWA, Nestel FP, Ni H, Lazarus AH, Freedman J and Semple JW (2006). 'Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-{alpha} production in vivo.' Blood 107(2): 637-641. Bayer A, Sullam P, Ramos M, Li C, Cheung A and Yeaman M (1995). 'Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains.' Infect. Immun. 63(9): 3634-3641. Beachey EH and Stollerman GH (1971). 'Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood.' The Journal of Experimental Medicine 134(2): 351-365. Born G and Patrono C (2006). 'Antiplatelet drugs.' British Journal of Pharmacology 147(S1): S241-S251. Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN and FitzGerald GA (2001). 'Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.' N Engl J Med 345(25): 1809-1817. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD, Keys EM, Allen-Vercoe E, DeVinney R, Doig CJ, Green FHY and Kubes P (2007). 'Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood.' Nat Med 13(4): 463-469. Czuprynski CJ and Balish E (1981). 'Interaction of rat platelets with Listeria monocytogenes.' Infect. Immun. 33(1): 103-108. Daly CG, Mitchell DH, Highfield JE, Grossberg DE and Stewart D (2001). 'Bacteremia due to periodontal probing: a clinical and microbiological investigation.' Journal of Periodontology 72(2): 210-214. Dankert, J (2006). 'Interleukin 1{alpha} increases the susceptibility of rabbits to experimental viridans streptococcal endocarditis.' Infect. Immun. 74(2): 947-952. Dankert J, Krijgsveld J, van der Werff J, Joldersma W and Zaat SAJ (2001). 'Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis.' The Journal of Infectious Diseases 184(5): 597-605. de Gaetano G, Cerletti C and Evangelista V (1999). 'Recent advances in platelet-polymorphonuclear leukocyte interaction.' Pathophysiology of Haemostasis and Thrombosis 29(1): 41-49. Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, Kustos T, Henics T, Meinke A and Nagy E (2005). 'Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.' Clin. Diagn. Lab. Immunol. 12(3): 387-398. Elstad MR, McIntyre TM, Prescott SM and Zimmerman GA (1995). 'The interaction of leukocytes with platelets in blood coagulation.' Current Opinion in Hematology 2(1): 47-54. Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, Stein CS, Nieswandt B, Wang Y, Davidson BL and Ratliff TL (2003). 'Platelet-Mediated Modulation of adaptive immunity: a communication link between innate and adaptive immune compartments.' Immunity 19(1): 9-19. Erickson PR and Herzberg MC (1990). 'Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen from the surface of Streptococcus sanguis.' Journal of Biological Chemistry 265(24): 14080-14087. Faint, RW (1992). 'Platelet--neutrophil interactions: Their significance.' Blood Reviews 6(2): 83-91. Fitzgerald JR, Foster TJ and Cox D (2006). 'The interaction of bacterial pathogens with platelets.' Nat Rev Micro 4(6): 445-457. Foster TJ (2005). 'Immune evasion by staphylococci.' Nat Rev Micro 3(12): 948-958. Fowler J, Vance G, McIntyre LM, Yeaman MR, Peterson GE, Barth Reller L, Corey GR, Wray D and Bayer AS (2000). 'In vitro resistance to thrombin‐induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source.' The Journal of Infectious Diseases 182(4): 1251-1254. Fujita K, Matsumoto-Nakano M, Inagaki S and Ooshima T (2007). 'Biological functions of glucan-binding protein B of Streptococcus mutans.' Oral Microbiology and Immunology 22(5): 289-292. Graham MR, Virtaneva K, Porcella SF, Barry WT, Gowen BB, Johnson CR, Wright FA and Musser JM (2005). 'Group A streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies.' Am J Pathol 166(2): 455-465. Hamada S and Slade HD (1980). 'Biology, immunology, and cariogenicity of Streptococcus mutans.' Microbiol. Mol. Biol. Rev. 44(2): 331-384. Hawrylowicz C, Santoro S, Platt F and Unanue E (1989). 'Activated platelets express IL-1 activity.' J Immunol 143(12): 4015-4018. Herzberg MC, MacFarlane GD, Gong K, Armstrong NN, Witt AR, Erickson PR and Meyer MW (1992). 'The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis.' Infect. Immun. 60(11): 4809-4818. Ito HO (2006). 'Infective endocarditis and dental procedures: evidence, pathogenesis, and prevention.' The Journal of Medical Investigation 53(3,4): 189-198. Klinger MHF and Jelkmann W (2002). 'Review: role of blood platelets in infection and inflammation.' Journal of Interferon & Cytokine Research 22(9): 913-922. Krijgsveld J, Zaat SAJ, Meeldijk J, van Veelen PA, Fang G, Poolman B, Brandt E, Ehlert JE, Kuijpers AJ, Engbers GHM, Feijen J and Dankert J (2000). 'Thrombocidins, microbicidal proteins from human blood platelets, are c-terminal deletion products of CXC chemokines.' Journal of Biological Chemistry 275(27): 20374-20381. Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Sullam PM, Filler SG and Bayer AS (1999). 'Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects.' Circulation 99(21): 2791-2797. Kurpiewski GE, Forrester LJ, Campbell BJ and Barrett JT (1983). 'Platelet aggregation by Streptococcus pyogenes.' Infect. Immun. 39(2): 704-708. Levison M, Carrizosa J, Tanphaichitra D, Schick P and Rubin W (1977). 'Effect of aspirin on thrombogenesis and on production of experimental aortic valvular Streptococcus viridans endocarditis in rabbits.' Blood 49(4): 645-650. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA and Weyrich AS (2001). 'Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis.' The Journal of Cell Biology 154(3): 485-490. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ and Bahrani-Mougeot FK (2008). 'Bacteremia associated with toothbrushing and dental extraction.' Circulation 117(24): 3118-3125. Loughman A, Fitzgerald JR, Brennan MP, Higgins J, Downer R, Cox D and Foster TJ (2005). 'Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A.' Molecular Microbiology 57(3): 804-818. Mayer-Scholl A, Averhoff P and Zychlinsky A (2004). 'How do neutrophils and pathogens interact?' Current Opinion in Microbiology 7(1): 62-66. McLaughlin RA and Hoogewerf AJ (2006). 'Interleukin-1b-induced growth enhancement of Staphylococcus aureus occurs in biofilm but not planktonic cultures.' Microbial Pathogenesis 41(2-3): 67-79. Michelson AD (2010). 'Antiplatelet therapies for the treatment of cardiovascular disease.' Nat Rev Drug Discov 9(2): 154-169. Moreillon P and Que Y-A (2004). 'Infective endocarditis.' The Lancet 363(9403): 139-149. Movat HZ, Weiser WJ, Glynn MF and Mustard JF (1965). 'Platelet phagocytosis and aggregation.' The Journal of Cell Biology 27(3): 531-543. Nakano K, Fujita K, Nishimura K, Nomura R and Ooshima T (2005). 'Contribution of biofilm regulatory protein A of Streptococcus mutans, to systemic virulence.' Microbes and Infection 7(11-12): 1246-1255. Nakano K, Tsuji M, Nishimura K, Nomura R and Ooshima T (2006). 'Contribution of cell surface protein antigen PAc of Streptococcus mutans to bacteremia.' Microbes and Infection 8(1): 114-121. Nakatani S, Mitsutake K, Hozumi T, Yoshikawa J, Akiyama M, Yoshida K, Ishizuka N, Nakamura K, Taniguchi Y, Yoshioka K, Kawazoe K, Akaishi M, Niwa K, Nakazawa M, Kitamura S, Miyatake K (2003). 'Current characteristics of infective endocarditis in Japan : an analysis of 848 cases in 2000 and 2001.' Circulation Journal 67(11): 901-905. Nathan C (2006). 'Neutrophils and immunity: challenges and opportunities.' Nat Rev Immunol 6(3): 173-182. Nicolau D, Marangos M, Nightingale C and Quintiliani R (1995). 'Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis.' Antimicrob. Agents Chemother. 39(8): 1748-1751. Nicolau DP, Freeman CD, Nightingale CH, Quintiliani R, Coe CJ, Maderazo EG and Cooper BW (1993). 'Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis.' Infect. Immun. 61(4): 1593-1595. Nomura R, Nakano K and Ooshima T (2004). 'Contribution of glucan-binding protein C of Streptococcus mutans to bacteremia occurrence.' Archives of Oral Biology 49(10): 783-788. Pallasch TJ and Slots J (1996). 'Antibiotic prophylaxis and the medically compromised patient.' Periodontology 2000 10(1): 107-138. Patrono C (1994). 'Aspirin as an antiplatelet drug.' N Engl J Med 330(18): 1287-1294. Permpanich P, Kowolik MJ and Galli DM (2006). 'Resistance of fluorescent-labelled Actinobacillus actinomycetemcomitans strains to phagocytosis and killing by human neutrophils.' Cellular Microbiology 8(1): 72-84. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS and Klein NJ (1999). 'Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing.' British Journal of Haematology 106(2): 391-399. Rivera J, Vannakambadi G, Höök M and Speziale P (2007). 'Fibrinogen-binding proteins of Gram-positive bacteria.' Thromb Haemost 98(3):503-11 Russell MW, Wu H-Y, White PL, Kilian M and Henrichsen J (1992). 'Serum antibody responses to Streptococcus mutans antigens in humans systemically infected with oral streptococci.' Oral Microbiology and Immunology 7(6): 321-325. Saravia-Otten P, Muller H and Arvidson S (1997). 'Transcription of Staphylococcus aureus fibronectin binding protein genes is negatively regulated by agr and an agr-independent mechanism.' J. Bacteriol. 179(17): 5259-5263. Semple J and Freedman J (2010). 'Platelets and innate immunity.' Cellular and Molecular Life Sciences 67(4): 499-511. Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y, Ejiri J, Kobayashi S, Hirata K-i, Kawashima S and Yokoyama M (2004). 'Expression of Toll-like receptors on human platelets.' Thrombosis Research 113(6): 379-385. Shun C-T, Lu S-Y, Yeh C-Y, Chiang C-P, Chia J-S and Chen J-Y (2005). 'Glucosyltransferases of viridans streptococci are modulins of interleukin-6 induction in infective endocarditis.' Infect. Immun. 73(6): 3261-3270. Sullam P, Bayer A, Foss W and Cheung A (1996). 'Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis.' Infect. Immun. 64(12): 4915-4921. Sullam PM, Valone FH and Mills J (1987). 'Mechanisms of platelet aggregation by viridans group streptococci.' Infect. Immun. 55(8): 1743-1750. Takahashi Y, Yajima A, Cisar JO and Konishi K (2004). 'Functional analysis of the Streptococcus gordonii DL1 sialic acid-binding adhesin and its essential role in bacterial binding to platelets.' Infect. Immun. 72(7): 3876-3882. Thiene G and Basso C (2006). 'Pathology and pathogenesis of infective endocarditis in native heart valves.' Cardiovascular Pathology 15(5): 256-263. Tsuda H, Yamashita Y, Toyoshima K, Yamaguchi N, Oho T, Nakano Y, Nagata K and Koga T (2000). 'Role of serotype-specific polysaccharide in the resistance of Streptococcus mutans to phagocytosis by human polymorphonuclear leukocytes.' Infect. Immun. 68(2): 644-650. Weichman BM (1988). 'Inflammation: basic principles and clinical correlates.' Inflammation Research 25(1): 205-206. Weyrich AS and Zimmerman GA (2004). 'Platelets: signaling cells in the immune continuum.' Trends in Immunology 25(9): 489-495. Wu B, Liu G, Yube K, Ueno M, Tanaka S, Onodera M, Jin Z and Sakamoto H (2009). 'Effects of platelet release products on neutrophilic activity in human whole blood.' Inflammation Research 58(6): 321-328. Wu T, Yeaman MR and Bayer AS (1994). 'In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates.' Antimicrob. Agents Chemother. 38(4): 729-732. Yajima A, Takahashi Y and Konishi K (2005). 'Identification of platelet receptors for the Streptococcus gordonii DL1 sialic acid-binding adhesin.' Microbiol Immunol 49(8):795-800 Yeaman M (2010). 'Platelets in defense against bacterial pathogens.' Cellular and Molecular Life Sciences 67(4): 525-544. Yeaman MR, Puentes SM, Norman DC and Bayer AS (1992). 'Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein.' Infect. Immun. 60(3): 1202-1209. Zwaal RFA, Comfurius P and Van Deenen LLM (1977). 'Membrane asymmetry and blood coagulation.' Nature 268(5618): 358-360. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/46428 | - |
| dc.description.abstract | 轉糖鏈球菌(Streptococcus mutans)為草綠色鏈球菌屬(viridans streptococci)，是人類口腔中常見的菌叢，會造成牙菌斑及齲齒，平時並不會對人體造成傷害，當口腔因外科手術或咀嚼造成傷口後，細菌就有機會進入血液中，形成短暫性菌血症，若再加上缺陷的心臟瓣膜或是人工心瓣膜，細菌就有機會黏附住瓣膜形成贅生物，有機會發展為感染性心內膜炎(infective endocarditis)。因此細菌在血液循環中抵抗先天性免疫反應並存活，是成為感染性心內膜炎最重要的致病機轉之一。先前的研究已知轉糖鏈球菌可以藉由其表面的一些分子直接或間接活化血小板或活化凝血機轉，並有抗體及纖維蛋白（fibrin）的參與。故本實驗即假設轉糖鏈球菌在進入血液循環後，會團聚血小板，並藉此團聚作用抵抗先天免疫反應，增加其在血液中的存活率。從實驗結果證實在血液循環中，轉糖鏈球菌確能與血小板形成團聚，而且在動物體內模式及體外人血模式下都發現類似的團聚現象。從全血殺菌能力測試(whole blood killing assay)中也發現，若添加血小板抑制劑阿斯匹靈（aspirin），轉糖鏈球菌在全血內的存活率明顯下降；若先將轉糖鏈球菌與血小板濃厚血漿(platelet rich plasma) 培養，可發現轉糖鏈球菌在全血殺菌能力測試中的存活率明顯上升，相同的現象也在白血球殺菌試驗中被發現，顯示血小板在細菌抵抗先天免疫反應的作用上扮演了一部份的角色。同樣的給與大鼠注射阿斯匹靈以後，會增進轉糖鏈球菌在血液循環中被清除的數量。此外血小板萃取物會刺激細菌，提升轉糖鏈球菌在血液中的存活率，並可能被細菌代謝利用，以促進細菌生長。但在以往研究也發現血小板能夠促進嗜中性球的殺菌能力，而在我的系統下，血小板與嗜中性球是有很高的機會可以進行交互作用。這樣的結果也顯示在血液循環中的血小板對於細菌性感染可扮演促進清除細菌的角色，也能扮演幫助轉糖鏈球菌抵抗免疫系統的角色。 | zh_TW |
| dc.description.abstract | Streptococcus mutans, a Gram-positive bacterium, is one of the pathogens of dental caries and also an opportunistic pathogen of infective endocarditis (IE). Dissemination of Streptococcus mutans into the bloodstream is known to be induced bacteremia caused during dental surgery or oral trauma. Circulating bacteria may escape host immune surveillance and subsequently adhere to the damaged valve to form vegetation (fibrin-platelet bacterial biofilm). Our laboratory demonstrated previously that Streptococcus mutans could directly bind to platelets and induce platelet aggregation. In this study, I demonstrated found that upon entering circulation in rats, Streptococcus mutans interact with platelets and form aggregation with platelets. Similar results were also observed in human blood in vitro and the bacteria survival rates were reduced by platelet activation inhibitor, aspirin. Preincubating with platelet rich plasma, Streptococcus mutans could form aggregation with platelets and also increase survival rates in whole blood or neutrophil killing; but reduce survival rate by aspirin. After the injection of aspirin in vivo, Streptococcus mutans clearance in bloodstream was also enhanced. These results suggested that bacteria aggregation with platelets is important in the bacteria resistance to host immune surveillance. But platelets sonication supernatant induced growth enhancement of Streptococcus mutans occurs in GS5 and clinical-isolate strain. These results suggest that in blood circulation platelets could play dual roles in bacterial infection: Streptococcus mutans subvert platelet function to help bacteria survival; platelets enhance bacteria clearance through neutrophils | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T05:08:33Z (GMT). No. of bitstreams: 1 ntu-99-R97445117-1.pdf: 1038492 bytes, checksum: d11978d05b5bfd85efccdb7a95a7630b (MD5) Previous issue date: 2010 | en |
| dc.description.tableofcontents | 目錄
口試委員會審定書 i 誌謝 ii 中文摘要 iii Abstract iv 目錄 vi 圖表目錄 viii 壹、緒論 1 一、轉糖鏈球菌（Streptococcus mutans） 1 二、感染性心內膜炎 2 三、菌血症（bacteremia） 3 四、細菌毒性因子與感染性心內膜炎的發生 4 五、血小板功能 5 六、血小板-白血球複合物 7 七、血小板與細菌間的交互作用 10 八、血小板與感染性心內膜炎 11 九、血小板分泌物對細菌的影響 13 十、研究目的與實驗設計 14 貳、實驗材料與方法 15 一、轉糖鏈球菌（Streptococcus mutans）的轉形作用 15 二、菌血症大老鼠動物模式 15 三、血液處理與以抗體anti-CD42d染團聚轉糖鏈球菌中血小板之方法 16 四、體外人體血液模式的建立與染色 16 五、全血殺菌能力試驗(whole blood killing assay) 16 六、轉糖鏈球菌與血小板濃厚血漿（platelet-rich plasma, PRP）、乏血小板血漿（platelet-poor plasma, PPP）共同培養之方法及全血殺菌試驗 17 七、人類嗜中性球(neutrophil)之分離與純化 18 八、人類嗜中性球殺菌能力試驗（neutrophil killing assay） 18 九、血小板超音波震盪上清液/粗萃取物（platelet-sonication-supernatants）的製備 19 十、血小板粗萃取物促進轉糖鏈球菌生長之試驗 19 叁、結果 21 第一部分：轉糖鏈球菌在血液循環中呈現的型態 21 1.轉糖鍊球菌在大鼠血液循環中的型態 21 2.轉糖鏈球菌在體外模型—人類血液中呈現的型態 21 第二部份：血小板在轉糖鏈球菌團聚構造中所扮演的角色 22 1.血小板活化對於轉糖鏈球菌在血液中存活率的影響 22 2.血小板與轉糖鏈球菌的團聚構造提升細菌在血液中的存活率 23 3.以大鼠菌血症模型來探討血小板對於轉糖鏈球菌存活在血液中的影 響 24 4.人類嗜中性球殺菌試驗的結果 25 第三部份：血小板分泌物對轉糖鏈球菌的影響 27 1.血小板粗萃取物促進轉糖鏈球菌的生長 27 2.血小板粗萃取物的其他功用 27 肆、討論 28 一、血小板參與轉糖鏈球菌所引起的菌血症—在血液中的團聚構造 28 二、利用血小板濃厚血漿/乏血小板血漿與轉糖鏈球菌共同培養來探討血小板的功用 29 三、血小板提升轉糖鏈球菌在血液中存活率的機制探討 30 四、血小板釋放物質的功用 32 五、阿斯匹靈對於治療感染性心內膜的探討 33 六、感染性心內膜炎的預防--阿斯匹靈的效用? 37 伍、結論 38 陸、參考文獻 40 | |
| dc.language.iso | zh-TW | |
| dc.subject | 感染性心內膜炎 | zh_TW |
| dc.subject | 轉糖鏈球菌 | zh_TW |
| dc.subject | 血小板 | zh_TW |
| dc.subject | infective endocarditis | en |
| dc.subject | platelet | en |
| dc.subject | Streptococcus mutans | en |
| dc.title | 轉糖鏈球菌與血小板形成團聚構造提升在血液循環中的存活率 | zh_TW |
| dc.title | Aggregation with Platelets Enhances Streptococcus mutans Survival in Blood Circulation | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 98-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 林淑華,顧家綺 | |
| dc.subject.keyword | 轉糖鏈球菌,感染性心內膜炎,血小板, | zh_TW |
| dc.subject.keyword | Streptococcus mutans,infective endocarditis,platelet, | en |
| dc.relation.page | 61 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2010-07-26 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 微生物學研究所 | zh_TW |
| 顯示於系所單位： | 微生物學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-99-1.pdf 未授權公開取用 | 1.01 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。